Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Myovant Sciences Total Assets 2017-2018 | MYOV

Myovant Sciences total assets from 2017 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Myovant Sciences Annual Total Assets
(Millions of US $)
2018 $119
2017 $185
2016 $0
Myovant Sciences Quarterly Total Assets
(Millions of US $)
Q3 2018 $202
Q2 2018 $168
Q1 2018 $154
Q4 2018 $119
Q3 2017 $138
Q2 2017 $136
Q1 2017 $163
Q4 2017 $185
Q3 2016 $194
Q2 2016 $2
Q1 2016 $1
Q4 2016 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.720B $0.000B
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $118.930B 13.26
Gilead Sciences (GILD) United States $82.398B 10.49
Biogen (BIIB) United States $63.063B 12.22
Celgene (CELG) United States $62.067B 11.48
Illumina (ILMN) United States $46.349B 55.12
Vertex Pharmaceuticals (VRTX) United States $46.013B 61.64
Regeneron Pharmaceuticals (REGN) United States $44.311B 20.58
Alexion Pharmaceuticals (ALXN) United States $29.422B 18.24
Incyte (INCY) United States $18.475B 172.62
BioMarin Pharmaceutical (BMRN) United States $16.046B 0.00
Seattle Genetics (SGEN) United States $11.684B 0.00
Exact Sciences (EXAS) United States $11.379B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.423B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
QIAGEN (QGEN) Netherlands $9.023B 29.86
Sarepta Therapeutics (SRPT) United States $8.830B 0.00
Bluebird Bio (BLUE) United States $8.439B 0.00
BeiGene (BGNE) Cayman Islands $7.982B 0.00
Guardant Health (GH) United States $7.569B 0.00
Bio-Techne Corp (TECH) United States $7.497B 50.51
Exelixis (EXEL) United States $7.317B 17.05
Moderna (MRNA) United States $6.580B 0.00
Amarin (AMRN) Ireland $6.139B 0.00
Alkermes (ALKS) Ireland $5.391B 0.00
Array BioPharma (ARRY) United States $5.335B 0.00
Galapagos (GLPG) Belgium $5.290B 0.00
Ascendis Pharma (ASND) Denmark $5.228B 0.00
Horizon Pharma Public (HZNP) Ireland $4.729B 15.23
Spark Therapeutics (ONCE) United States $4.309B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.246B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.773B 0.00
Blueprint Medicines (BPMC) United States $3.677B 0.00
Immunomedics (IMMU) United States $3.494B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.490B 0.00
China Biologic Products (CBPO) China $3.441B 21.32
Intercept Pharmaceuticals (ICPT) United States $3.358B 0.00
Allogene Therapeutics (ALLO) United States $3.154B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.026B 0.00
Amicus Therapeutics (FOLD) United States $2.991B 0.00
Global Blood Therapeutics (GBT) United States $2.881B 0.00
Reata Pharmaceuticals (RETA) United States $2.710B 0.00
Genomic Health (GHDX) United States $2.709B 69.26
Repligen (RGEN) United States $2.612B 80.38
Akcea Therapeutics (AKCA) United States $2.587B 0.00
Mirati Therapeutics (MRTX) United States $2.566B 0.00
Ligand Pharmaceuticals (LGND) United States $2.529B 18.89
UniQure (QURE) Netherlands $2.477B 0.00
Emergent Biosolutions (EBS) United States $2.469B 20.61
Myriad Genetics (MYGN) United States $2.421B 24.66
Halozyme Therapeutics (HALO) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.338B 0.00
Insmed (INSM) United States $2.223B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.209B 0.00
REGENXBIO (RGNX) United States $2.207B 23.04
Arena Pharmaceuticals (ARNA) United States $2.203B 0.00
MyoKardia (MYOK) United States $2.197B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.181B 0.00
Denali Therapeutics (DNLI) United States $2.083B 0.00
Medicines (MDCO) United States $1.998B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.940B 0.00
AnaptysBio (ANAB) United States $1.915B 0.00
NeoGenomics (NEO) United States $1.838B 149.54
Atara Biotherapeutics (ATRA) United States $1.794B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.745B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Allakos (ALLK) United States $1.641B 0.00
Puma Biotechnology (PBYI) United States $1.520B 0.00
WAVE Life Sciences (WVE) Singapore $1.509B 0.00
GOSSAMER BIO (GOSS) United States $1.472B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.452B 0.00
Innoviva (INVA) United States $1.409B 3.88
Momenta Pharmaceuticals (MNTA) United States $1.356B 0.00
Clovis Oncology (CLVS) United States $1.338B 0.00
Aimmune Therapeutics (AIMT) United States $1.315B 0.00
Rubius Therapeutics (RUBY) United States $1.306B 0.00
Cambrex (CBM) United States $1.299B 13.99
ALECTOR INC (ALEC) United States $1.292B 0.00
Lion Biotechnologies (IOVA) United States $1.237B 0.00
Apellis Pharmaceuticals (APLS) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Fate Therapeutics (FATE) United States $1.147B 0.00
Codexis (CDXS) United States $1.141B 0.00
Epizyme (EPZM) United States $1.085B 0.00
InflaRx (IFRX) Germany $1.081B 0.00
RA PHARMCTL INC (RARX) United States $1.057B 0.00
Coherus BioSciences (CHRS) United States $1.045B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.041B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.987B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.985B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.980B 0.00
Retrophin (RTRX) United States $0.977B 0.00
Sangamo Therapeutics (SGMO) United States $0.975B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.943B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.942B 38.08
Dicerna Pharmaceuticals (DRNA) United States $0.929B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.922B 0.00
Principia Biopharma (PRNB) United States $0.869B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.833B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.823B 0.00
Athenex (ATNX) United States $0.814B 0.00
Vericel (VCEL) United States $0.810B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.800B 0.00
Cellectis (CLLS) France $0.794B 0.00
Eidos Therapeutics (EIDX) United States $0.770B 0.00
Intellia Therapeutics (NTLA) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.766B 0.00
ANI Pharmaceuticals (ANIP) United States $0.764B 13.98
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.708B 0.00
Revance Therapeutics (RVNC) United States $0.699B 0.00
Intra-Cellular Therapies (ITCI) United States $0.694B 0.00
Synthorx (THOR) United States $0.670B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.670B 0.00
Osiris Therapeutics (OSIR) United States $0.664B 0.00
Twist Bioscience (TWST) United States $0.652B 0.00
Acorda Therapeutics (ACOR) United States $0.652B 8.45
Heska (HSKA) United States $0.647B 57.99
Magenta Therapeutics (MGTA) United States $0.597B 0.00
Viking Therapeutics (VKTX) United States $0.595B 0.00
Kura Oncology (KURA) United States $0.586B 0.00
ObsEva SA (OBSV) Switzerland $0.581B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.580B 0.00
Stemline Therapeutics (STML) United States $0.566B 0.00
G1 THERAPEUTICS (GTHX) United States $0.562B 0.00
Cytokineticsorporated (CYTK) United States $0.559B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Zealand Pharma (ZEAL) Denmark $0.545B 6.00
Prothena (PRTA) Ireland $0.544B 0.00
MeiraGTx Holdings (MGTX) United States $0.539B 0.00
UROGEN PHARMA (URGN) Israel $0.516B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.516B 0.00
Arcus Biosciences (RCUS) United States $0.514B 0.00
Scholar Rock Holding (SRRK) United States $0.498B 0.00
Zymeworks (ZYME) Canada $0.494B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.484B 0.00
Dynavax Technologies (DVAX) United States $0.482B 0.00
PDL BioPharma (PDLI) United States $0.474B 10.57
Five Prime Therapeutics (FPRX) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Replimune (REPL) United States $0.447B 0.00
AVROBIO (AVRO) United States $0.446B 0.00
Senesco Technologies (ELOX) United States $0.436B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.433B 0.00
Sorrento Therapeutics (SRNE) United States $0.427B 0.00
Anika Therapeutics (ANIK) United States $0.424B 16.03
Achillion Pharmaceuticals (ACHN) United States $0.415B 0.00
MannKind (MNKD) United States $0.414B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.407B 0.00
BeyondSpring (BYSI) United States $0.400B 0.00
Axsome Therapeutics (AXSM) United States $0.400B 0.00
XBiotech (XBIT) United States $0.397B 0.00
Agenus (AGEN) United States $0.389B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
UNITY Biotechnology (UBX) $0.378B 0.00
Abeona Therapeutics (ABEO) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 0.00
STEALTH BIOTHER (MITO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Adverum Biotechnologies (ADVM) United States $0.369B 0.00
Albireo Pharma (ALBO) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
MediciNova (MNOV) United States $0.360B 0.00
Urovant Sciences (UROV) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.351B 0.00
Kezar Life Sciences (KZR) United States $0.351B 0.00
Gritstone Oncology (GRTS) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.338B 0.00
Geron (GERN) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
OSMOTICA PHARM (OSMT) United States $0.329B 0.00
Krystal Biotech (KRYS) United States $0.320B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Protagonist Therapeutics (PTGX) United States $0.307B 0.00
AC Immune SA (ACIU) Switzerland $0.306B 0.00
Syros Pharmaceuticals (SYRS) United States $0.300B 0.00
Strongbridge Biopharma (SBBP) United States $0.300B 0.00
Merus (MRUS) Netherlands $0.292B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.285B 0.00
Gamida Cell (GMDA) Israel $0.284B 0.00
Novavax (NVAX) United States $0.283B 0.00
Kala Pharmaceuticals (KALA) United States $0.279B 0.00
Enochian BioSciences (ENOB) United States $0.278B 0.00
Seres Therapeutics (MCRB) United States $0.277B 0.00
Evelo Biosciences (EVLO) United States $0.269B 0.00
Verastem (VSTM) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.251B 0.00
Cerecor (CERC) United States $0.250B 0.00
BioTime (BTX) United States $0.245B 0.00
Avid Bioservices (CDMO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.244B 0.00
Kamada (KMDA) Israel $0.238B 10.74
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Athersys (ATHX) United States $0.231B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Celyad SA (CYAD) Belgium $0.223B 0.00
Axovant Sciences (AXGT) United Kingdom $0.222B 0.00
Intec Pharma (NTEC) Israel $0.222B 0.00
Proteostasis Therapeutics (PTI) United States $0.221B 0.00
Mersana Therapeutics (MRSN) United States $0.219B 0.00
LogicBio Therapeutics (LOGC) United States $0.219B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Liquidia Technologies (LQDA) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.210B 0.00
Palatin Technologies (PTN) United States $0.205B 101.00
Celcuity (CELC) United States $0.203B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.202B 0.00
Synlogic (SYBX) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.194B 0.00
Compugen (CGEN) Israel $0.193B 0.00
Cue Biopharma (CUE) United States $0.193B 0.00
Pfenex (PFNX) United States $0.192B 0.00
OvaScience (MLND) United States $0.188B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.182B 0.00
ADMA Biologics Inc (ADMA) United States $0.181B 0.00
ResTORbio (TORC) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.177B 0.00
Trevena (TRVN) United States $0.171B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.154B 0.00
BioXcel Therapeutics (BTAI) United States $0.154B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Chiasma (CHMA) United States $0.152B 0.00
Allena Pharmaceuticals (ALNA) United States $0.150B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.141B 0.00
Unum Therapeutics (UMRX) United States $0.139B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Equillium (EQ) United States $0.127B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.127B 0.00
Enzo Biochem (ENZ) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.115B 0.00
Mustang Bio (MBIO) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.111B 0.00
VolitionRX (VNRX) Singapore $0.110B 0.00
Signal Genetics (MGEN) United States $0.105B 0.00
NantKwest (NK) United States $0.104B 0.00
Neothetics (EVFM) United States $0.104B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.097B 0.00
Cel-Sci (CVM) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
Provention Bio (PRVB) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.083B 93.00
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Oncobiologics (OTLK) United States $0.081B 0.00
Alimera Sciences (ALIM) United States $0.080B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
NewLink Genetics (NLNK) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
SESEN BIO, INC (SESN) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.073B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.069B 13.16
Prima BioMed (IMMP) Australia $0.066B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.064B 0.00
Ophthotech (OPHT) United States $0.064B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Proteon Therapeutics (PRTO) United States $0.062B 0.00
Vascular Biogenics (VBLT) Israel $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
Alcobra (ARCT) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
Arsanis (XFOR) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.050B 0.00
Vaccinex (VCNX) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.049B 0.00
Evogene (EVGN) Israel $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Leap Therapeutics (LPTX) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
Celsion (CLSN) United States $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Motif Bio Plc (MTFB) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.036B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoSec Medical (ONCS) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
GTx (GTXI) United States $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.030B 0.00
BioPharmX (BPMX) United States $0.029B 0.00
Adial Pharmaceuticals (ADIL) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Vical (VICL) United States $0.026B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.54
Genetic Technologies (GENE) Australia $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Apricus Biosciences (SEEL) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Pulmatrix (PULM) United States $0.012B 0.00
Neuralstem (CUR) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00